Faculty of Science: Recent submissions
-
Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic.
Published 2020We included all 74,960 olanzapine LAI dispensings listed in the Pharmaceutical Benefits Schedule (PBS) database from the introduction of olanzapine LAI in January 2010 until the end of January 2020. Adverse event reports ...Article -
Providing quality end-of-life care to older people in the era of COVID-19: perspectives from five countries
Published 2020This paper will explore the key challenges currently afoot in providing quality end-of-life care to older people in the COVID pandemic from the perspective of clinicians and researchers from five countries. We explore ways ...Article -
Effective health communication – a key factor in fighting the COVID-19 pandemic
Published 2020Over the course of March 2020, the everyday life of most people changed from normal to extraordinary around the globe. By the beginning of March, there had been serious outbreaks of COVID-19 in a limited number of countries, ...Article -
Coronavirus disease 2019 (COVID‐19): angiotensin‐converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease
Published 2020As the world watches the spread of the coronavirus disease 2019 (COVID‐19) pandemic, affecting the health of millions of people and the lives of everyone, common health conditions including heart disease, stroke, cancer ...Article -
COVID-19 and alcohol in Australia: Industry changes and public health impacts
Published 2020The COVID-19 pandemic is having an unprecedented impact on every aspect of our lives, including the way we drink alcohol. The Australian Government has implemented strict social distancing measures to contain and prevent ...Article